GlassScriptPhysician profile
Zackery R Devine
NPI 1700487147
$483.34
in general payments reported to CMS, 2019-2025
10 companies · $65.55 in 2025
The $65.55 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $237 · 2022: $75.18 · 2024: $106 · 2025: $65.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $153.79 | 2021-2024 | Belbuca |
| Almatica Pharma LLC | $63.20 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $54.64 | 2021 | |
| Grt US Holding, INC. | $53.59 | 2021-2022 | |
| Amgen INC. | $41.44 | 2021-2025 | Krystexxa |
| Nalu Medical, INC. | $35.11 | 2024 | Nalu Neurostimulation System |
| Janssen Pharmaceuticals, INC | $23.45 | 2025 | Spravato |
| Radius Health, INC. | $21.26 | 2022 | |
| Si-Bone, INC. | $20.05 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $16.81 | 2025 | Iqirvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zackery Devine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.